Vasculitis

Vasculitis

Micrograph showing a vasculitis (Churg-Strauss syndrome). H&E stain.
Classification and external resources
ICD-10 I77.6, I80, L95, M30-M31
ICD-9 446, 447.6
DiseasesDB 13750
Patient UK Vasculitis
MeSH D014657

Vasculitis (plural: vasculitides)[1] is a group of disorders that destroy blood vessels by inflammation.[2] Both arteries and veins are affected. Lymphangitis is sometimes considered a type of vasculitis.[3] Vasculitis is primarily caused by leukocyte migration and resultant damage.

Although both occur in vasculitis, inflammation of veins (phlebitis) or arteries (arteritis) on their own are separate entities.

Signs and symptoms

Petechia and purpura on the lower limb due to medication-induced vasculitis.

Possible symptoms include:[4]

Cause

Classification

Vasculitis can be classified by the cause, the location, the type of vessel or the size of vessel.

According to the size of the vessel affected, vasculitis can be classified into:[6]

Conditions

Some disorders have vasculitis as their main feature. The major types are given in the table below:

Comparison of major types of vasculitis
Vasculitis Affected organs Histopathology
Cutaneous small-vessel vasculitis Skin, kidneys Neutrophils, fibrinoid necrosis
Granulomatosis with polyangiitis Nose, lungs, kidneys Neutrophils, giant cells
Churg–Strauss syndrome Lungs, kidneys, heart, skin Histiocytes, eosinophils
Behçet's disease Commonly sinuses, brain, eyes and skin; can affect other organs such as lungs, kidneys, joints;
Kawasaki disease Skin, heart, mouth, eyes Lymphocytes, endothelial necrosis
Buerger's disease Leg arteries and veins (gangrene) Neutrophils, granulomas
"Limited" granulomatosis with polyangiitis vasculitis Commonly sinuses, brain, and skin; can affect other organs such as lungs, kidneys, joints;

Takayasu's arteritis, polyarteritis nodosa and giant cell arteritis mainly involve arteries and are thus sometimes classed specifically under arteritis.

Furthermore, there are many conditions that have vasculitis as an accompanying or atypical symptom, including:

Several of these vasculitides are associated with antineutrophil cytoplasmic antibodies.[7] These are

Diagnosis

Severe vasculitis of the major vessels, displayed on FDG-PET/CT
Laboratory Investigation of Vasculitic Syndromes[8]
Disease Serologic test Antigen Associated laboratory features
Systemic lupus erythematosus ANA including antibodies to dsDNA and ENA [including SM, Ro (SSA), La (SSB), and RNP] Nuclear antigens Leukopenia, thrombocytopenia, Coombs' test, complement activation: low serum concentrations of C3 and C4, positive immunofluorescence using Crithidia luciliae as substrate, antiphospholipid antibodies (i.e., anticardiolipin, lupus anticoagulant, false-positive VDRL)
Goodpasture's disease Anti-glomerular basement membrane antibody Epitope on noncollagen domain of type IV collagen
Small vessel vasculitis
Microscopic polyangiitis Perinuclear antineutrophil cytoplasmic antibody Myeloperoxidase Elevated CRP
Granulomatosis with polyangiiitis Cytoplasmic antineutrophil cytoplasmic antibody Proteinase 3 (PR3) Elevated CRP
Churg-Strauss syndrome perinuclear antineutrophil cytoplasmic antibody in some cases Myeloperoxidase Elevated CRP and eosinophilia
Henoch-Schönlein purpura None
Cryoglobulinemia Cryoglobulins, rheumatoid factor, complement components, hepatitis C
Medium vessel vasculitis
Classical polyarteritis nodosa None Elevated CRP and eosinophilia

In this table: ANA = Antinuclear antibodies, CRP = C-reactive protein, dsDNA = double-stranded DNA, ENA = extractable nuclear antigens, RNP = ribonucleoproteins; VDRL = Venereal Disease Research Laboratory

Treatment

Treatments are generally directed toward stopping the inflammation and suppressing the immune system. Typically, corticosteroids such as prednisone are used. Additionally, other immune suppression drugs, such as cyclophosphamide and others, are considered. In case of an infection, antimicrobial agents including cephalexin may be prescribed. Affected organs (such as the heart or lungs) may require specific medical treatment intended to improve their function during the active phase of the disease.

References

  1. "Vasculitis - Definition from the Merriam-Webster Online Dictionary". Retrieved 2009-01-08.
  2. "Glossary of dermatopathological terms. DermNet NZ". Retrieved 2009-01-08.
  3. "Vasculitis" at Dorland's Medical Dictionary
  4. "The Johns Hopkins Vasculitis Center - Symptoms of Vasculitis". Retrieved 2009-05-07.
  5. Jennette JC, Falk RJ, Andrassy K et al. (1994). "Nomenclature of systemic vasculitides. Proposal of an international consensus conference". Arthritis Rheum. 37 (2): 187–92. doi:10.1002/art.1780370206. PMID 8129773.
  6. http://www.merckmanuals.com/professional/musculoskeletal_and_connective_tissue_disorders/vasculitis/overview_of_vasculitis.html
  7. Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L (2013) Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis
  8. Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 5th edition. Elsevier Saunders. p. 1568. ISBN 978-1-4160-6164-9.